Latest KPTI reports update at 2024-05-08: 2024-Q12023-Q42023-Q1
Karyopharm Therapeutics  logo
Karyopharm Therapeutics KPTI
$ 0.96 -6.23%

Karyopharm Therapeutics EV/EBITDA Ratio 2011-2024 | KPTI

Annual EV/EBITDA Ratio Karyopharm Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.17 -6.67 -5.21 -2.63 -3.71 -3.05 -1.38 -8.94 -1.32 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.32 -8.94 -4.57